Literature DB >> 29707263

PCI or CABG for unprotected left main coronary artery disease?-new evidence justifies a change in perspective.

R Andrew Archbold1.   

Abstract

Entities:  

Year:  2018        PMID： 29707263      PMCID： PMC5906374          DOI： 10.21037/jtd.2018.03.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.

Authors:  Kenichi Fujii; Stéphane G Carlier; Gary S Mintz; Yi-ming Yang; Issam Moussa; Giora Weisz; George Dangas; Roxana Mehran; Alexandra J Lansky; Edward M Kreps; Michael Collins; Gregg W Stone; Jeffrey W Moses; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

2.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Authors:  Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

3.  5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Pascal Vranckx; Bernard De Bruyne; Marie-Claude Morice; Antonio Colombo; Carlos Macaya; Gert Richardt; Jean Fajadet; Christian Hamm; Monique Schuijer; Tessa Rademaker; Kristel Wittebols; Hans Peter Stoll
Journal:  J Am Coll Cardiol       Date:  2010-02-18       Impact factor: 24.094

4.  Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

Authors:  Jung-Min Ahn; Jae-Hyung Roh; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Pil Hyung Lee; Mineok Chang; Hyun Woo Park; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Suk Jung Choo; CheolHyun Chung; JaeWon Lee; Do-Sun Lim; Seung-Woon Rha; Sang-Gon Lee; Hyeon-Cheol Gwon; Hyo-Soo Kim; In-Ho Chae; Yangsoo Jang; Myung-Ho Jeong; Seung-Jea Tahk; Ki Bae Seung; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

Review 5.  Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club.

Authors:  Jens Flensted Lassen; Francesco Burzotta; Adrian P Banning; Thierry Lefèvre; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Manuel Pan; Niels Ramsing Holm; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2018-01-20       Impact factor: 6.534

6.  Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.

Authors:  Angela Migliorini; Renato Valenti; Guido Parodi; Ruben Vergara; Piergiovanni Buonamici; Giampaolo Cerisano; Nazario Carrabba; David Antoniucci
Journal:  JACC Cardiovasc Interv       Date:  2016-05-23       Impact factor: 11.195

7.  Fifteen year survival study of patients with obstructive coronary artery disease.

Authors:  W J Proudfit; A V Bruschke; J P MacMillan; G W Williams; F M Sones
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

8.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

9.  Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Authors:  Marie-Claude Morice; Patrick W Serruys; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; James W Choi; Witold Ruzyllo; Grzegorz Religa; Jian Huang; Kristine Roy; Keith D Dawkins; Friedrich Mohr
Journal:  Circulation       Date:  2014-04-03       Impact factor: 29.690

10.  Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis.

Authors:  Yicong Ye; Ming Yang; Shuyang Zhang; Yong Zeng
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240
View more
  1 in total

1.  Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions.

Authors:  Hengdao Liu; Hailong Tao; Xufei Han; Yang Lu; Xiaofei Xue; Ruihan Feng; Fenghua Lv; Yanwei Liu; Hongrui Jin; Lianjie Li; Heping Gu
Journal:  J Interv Cardiol       Date:  2022-01-11       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.